Zydus Lifesciences (BOM:532321) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 11, 2026)


BOM:532321 Zydus Lifesciences Ltd BOM:532321
92 GF Score
Price ₹1,150.50
GF Value ₹1,152.39
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Zydus Lifesciences Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-07-11), Zydus Lifesciences's Predictability Rank is 3.5-Stars. Zydus Lifesciences's intrinsic value calculated from the Discounted FCF model is ₹790.02 and current share price is ₹1150.50. Consequently,

Zydus Lifesciences's Margin of Safety % (DCF FCF Based) using Discounted FCF model is N/A.

BOM:532321 vs ZTS, UTHR: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zydus Lifesciences's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zydus Lifesciences Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zydus Lifesciences's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Zydus Lifesciences's Margin of Safety % (DCF FCF Based) falls into.


BOM:532321
92GF Score
Zydus Lifesciences Ltd BOM:532321
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zydus Lifesciences Margin of Safety % (DCF FCF Based) Calculation

Zydus Lifesciences's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(-51.21-1150.50)/-51.21
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Is Zydus Lifesciences (BOM:532321) Overvalued in 2026?

Based on GuruFocus' analysis, Zydus Lifesciences stock appears to be undervalued. The current stock price of ₹1,150.50 is trading 0.2% below its estimated GF Value™ of ₹1,152.39. GuruFocus considers Zydus Lifesciences to be Fairly Valued.

Key valuation signals for BOM:532321:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₹1,152.39 vs. price of ₹1,150.50 (0.2% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the BOM:532321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zydus Lifesciences Business Description

Other Exchanges ZYDUSLIFE:India
Address Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481
Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. It is engaged in the research, development, production, marketing, and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients (API), human formulations, animal health and veterinary, and consumer health and wellness products. Its products are marketed under brands like Amlodac, Inditel, Pivasta, and others. The company's operating segments are: Pharmaceuticals, which derives key revenue, and Consumer products. Geographically, it generates maximum revenue from the United States, followed by India, and other countries.
92GF Score

Get the complete analysis for BOM:532321

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,150.50
Price
₹1,152.39
GF Value